198 related articles for article (PubMed ID: 2143421)
1. Intracellular inhibition of mono(ADP-ribosylation) by meta-iodobenzylguanidine: specificity, intracellular concentration and effects on glucocorticoid-mediated cell lysis.
Smets LA; Loesberg C; Janssen M; Van Rooij H
Biochim Biophys Acta; 1990 Aug; 1054(1):49-55. PubMed ID: 2143421
[TBL] [Abstract][Full Text] [Related]
2. Meta-iodobenzylguanidine (MIBG), a novel high-affinity substrate for cholera toxin that interferes with cellular mono(ADP-ribosylation).
Loesberg C; van Rooij H; Smets LA
Biochim Biophys Acta; 1990 Jan; 1037(1):92-9. PubMed ID: 2104758
[TBL] [Abstract][Full Text] [Related]
3. Potentiation of glucocorticoid-induced lysis in refractory and resistant leukemia cells by inhibitors of ADP-ribosylation.
Smets L; Metwally EA; Knol E; Martens M
Leuk Res; 1988; 12(9):737-43. PubMed ID: 3193812
[TBL] [Abstract][Full Text] [Related]
4. Effect of an arginine-specific ADP-ribosyltransferase inhibitor on differentiation of embryonic chick skeletal muscle cells in culture.
Kharadia SV; Huiatt TW; Huang HY; Peterson JE; Graves DJ
Exp Cell Res; 1992 Jul; 201(1):33-42. PubMed ID: 1612127
[TBL] [Abstract][Full Text] [Related]
5. Quantitative studies of inhibitors of ADP-ribosylation in vitro and in vivo.
Rankin PW; Jacobson EL; Benjamin RC; Moss J; Jacobson MK
J Biol Chem; 1989 Mar; 264(8):4312-7. PubMed ID: 2538435
[TBL] [Abstract][Full Text] [Related]
6. Biochemical pathways of apoptosis: nicotinamide adenine dinucleotide-deficient cells are resistant to tumor necrosis factor or ultraviolet light activation of the 24-kD apoptotic protease and DNA fragmentation.
Wright SC; Wei QS; Kinder DH; Larrick JW
J Exp Med; 1996 Feb; 183(2):463-71. PubMed ID: 8627159
[TBL] [Abstract][Full Text] [Related]
7. Repression of phosphoenolpyruvate carboxykinase gene activity by insulin is blocked by 3-aminobenzamide but not by PD128763, a selective inhibitor of poly(ADP-ribose) polymerase.
Yau L; Elliot T; Lalonde C; Zahradka P
Eur J Biochem; 1998 Apr; 253(1):91-100. PubMed ID: 9578465
[TBL] [Abstract][Full Text] [Related]
8. Gs alpha is a substrate for mono(ADP-ribosyl)transferase of NG108-15 cells. ADP-ribosylation regulates Gs alpha activity and abundance.
Donnelly LE; Boyd RS; MacDermot J
Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):331-6. PubMed ID: 1280114
[TBL] [Abstract][Full Text] [Related]
9. Specific inhibitors of poly(ADP-ribose) synthetase and mono(ADP-ribosyl)transferase.
Banasik M; Komura H; Shimoyama M; Ueda K
J Biol Chem; 1992 Jan; 267(3):1569-75. PubMed ID: 1530940
[TBL] [Abstract][Full Text] [Related]
10. MIBG, an inhibitor of arginine-dependent mono(ADP-ribosyl)ation, prevents differentiation of L6 skeletal myoblasts by inhibiting expression of myogenin and p21(cip1).
Yau L; Litchie B; Zahradka P
Exp Cell Res; 2004 Dec; 301(2):320-30. PubMed ID: 15530866
[TBL] [Abstract][Full Text] [Related]
11. Target proteins for arginine-specific mono(ADP-ribosyl) transferase in membrane fractions from chick skeletal muscle cells.
Huang HY; Zhou H; Huiatt TW; Graves DJ
Exp Cell Res; 1996 Jul; 226(1):147-53. PubMed ID: 8660950
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterisation of a fungal mono(ADP-ribosyl)transferase.
Deveze-Alvarez M; García-Soto J; Martínez-Cadena G
Adv Exp Med Biol; 1997; 419():155-62. PubMed ID: 9193648
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of 3T3-L1 pre-adipocytes induced by inhibitors of poly(ADP-ribose) polymerase and by related noninhibitory acids.
Janssen OE; Hilz H
Eur J Biochem; 1989 Apr; 180(3):595-602. PubMed ID: 2523799
[TBL] [Abstract][Full Text] [Related]
14. Endogenous mono-ADP-ribosylation mediates smooth muscle cell proliferation and migration via protein kinase N-dependent induction of c-fos expression.
Yau L; Litchie B; Thomas S; Storie B; Yurkova N; Zahradka P
Eur J Biochem; 2003 Jan; 270(1):101-10. PubMed ID: 12492480
[TBL] [Abstract][Full Text] [Related]
15. Meta-iodobenzylguanidine, an inhibitor of arginine-dependent mono(ADP-ribosyl)ation, prevents neointimal hyperplasia.
Yau L; Molnar P; Moon MC; Buhay S; Werner JP; Molnar K; Saward L; Del Rizzo D; Zahradka P
J Pharmacol Exp Ther; 2008 Sep; 326(3):717-24. PubMed ID: 18523160
[TBL] [Abstract][Full Text] [Related]
16. Role of ADP-ribosylation in endothelial signal transduction and prostacyclin production.
Halldórsson H; Bödvarsdóttir T; Kjeld M; Thorgeirsson G
FEBS Lett; 1992 Dec; 314(3):322-6. PubMed ID: 1468563
[TBL] [Abstract][Full Text] [Related]
17. Poly(ADP-ribose) Polymerase inhibitors preserve nicotinamide adenine dinucleotide and adenosine 5'-triphosphate pools in DNA-damaged cells: mechanism of stimulation of unscheduled DNA synthesis.
Sims JL; Berger SJ; Berger NA
Biochemistry; 1983 Oct; 22(22):5188-94. PubMed ID: 6317018
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of bleomycin activity by 3-aminobenzamide, a poly (ADP-ribose) synthesis inhibitor, in vitro and in vivo.
Kato T; Suzumura Y; Fukushima M
Anticancer Res; 1988; 8(2):239-43. PubMed ID: 2452600
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of ADP-ribosylation suppress phenotypic modulation and proliferation of smooth muscle cells cultured from rat aorta.
Thyberg J; Hultgårdh-Nilsson A; Kallin B
Differentiation; 1995 Nov; 59(4):243-52. PubMed ID: 8575646
[TBL] [Abstract][Full Text] [Related]
20. ADP-ribosylation, DNA repair, cell differentiation and cancer.
Shall S
Princess Takamatsu Symp; 1983; 13():3-25. PubMed ID: 6317641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
